Arcutis Biotherapeutics, Inc. (ARQT) Financial Statements (2024 and earlier)

Company Profile

Business Address 3027 TOWNSGATE ROAD
WESTLAKE VILLAGE, CA 91361
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments409,589387,059284,441
Cash and cash equivalents53,64196,44965,082
Short-term investments355,948290,610219,359
Receivables8,458  
Inventory, net of allowances, customer advances and progress billings7,514  
Inventory7,514  
Prepaid expense7,2138,1811,468
Other undisclosed current assets4,6327,5336,917
Total current assets:437,406402,773292,826
Noncurrent Assets
Operating lease, right-of-use asset2,7213,0403,349
Property, plant and equipment1,8812,2612,016
Intangible assets, net (including goodwill)7,188  
Intangible assets, net (excluding goodwill)7,188  
Other noncurrent assets787878
Total noncurrent assets:11,8685,3795,443
TOTAL ASSETS:449,274408,152298,269
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities37,15032,89322,602
Accounts payable8,8277,3537,140
Accrued liabilities28,32325,54015,462
Other undisclosed current liabilities657433 
Total current liabilities:37,80733,32622,602
Noncurrent Liabilities
Long-term debt and lease obligation197,76977,1244,964
Long-term debt, excluding current maturities197,76972,350 
Liabilities, other than long-term debt4,1172582
Other liabilities  2582
Operating lease, liability4,1174,7744,964
Total noncurrent liabilities:201,88677,1495,046
Total liabilities:239,693110,47527,648
Equity
Equity, attributable to parent209,581297,677270,621
Common stock654
Additional paid in capital930,425706,233472,569
Accumulated other comprehensive loss(1,086)(255)(2)
Accumulated deficit(719,764)(408,306)(201,950)
Total equity:209,581297,677270,621
TOTAL LIABILITIES AND EQUITY:449,274408,152298,269

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Revenues3,686  
Gross profit:3,686  
Operating expenses(305,313)(206,529)(136,645)
Operating loss:(301,627)(206,529)(136,645)
Nonoperating income (expense)(9,831)173967
Other nonoperating income5,821  
Interest and debt expense(15,652)  
Loss from continuing operations before income taxes:(327,110)(206,356)(135,678)
Income tax expense   
Loss from continuing operations:(327,110)(206,356)(135,678)
Loss before gain (loss) on sale of properties:(206,356)(135,678)
Net loss:(327,110)(206,356)(135,678)
Other undisclosed net income attributable to parent15,652  
Net loss available to common stockholders, diluted:(311,458)(206,356)(135,678)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Net loss:(327,110)(206,356)(135,678)
Comprehensive loss:(327,110)(206,356)(135,678)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent14,821(253)(1)
Comprehensive loss, net of tax, attributable to parent:(312,289)(206,609)(135,679)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: